MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The non-motors symptoms in Parkinson’s disease patients with freezing of gait

    H.C. Huang, M.K. Lu, C.H. Tsai (Taichung, Taiwan)

    Objective: To reveal the prevalence of the non-motors symptoms and clinical features differences between Parkinson's disease (PD) patients with and without freezing of gait (FOG).…
  • 2016 International Congress

    The effects of dysphagia course for speech & language pathologist in Israel on clinical-related knowledge and confidence

    Y. Manor, H. Shabtai, O. Sella (Tel-Aviv, Israel)

    Objective: We assessed the accuracy of dysphagia management-related knowledge of SLPs in Israel before and after a 60-hour course on dysphagia. Background: Dysphagia management among…
  • 2016 International Congress

    Parkinson’s disease prodromal dysautonomia versus pure autonomic failure and MSA

    M. Rosso, A. Merola, A.J. Espay, S. Maule, M. Zibetti, A. Romagnolo, L. Lopiano (Torino, Italy)

    Objective: To report the long-term follow-up (10 years) of a patient with severe autonomic dysfunction as presenting symptom of Parkinson's disease (PD), analyzing the possible…
  • 2016 International Congress

    Longitudinal evolution of possible REM sleep behavior disorder in early Parkinson’s disease

    W. Oertel, T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, A. Iranzo, G. Mayer, L. Chahine, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Marburg, Germany)

    Objective: To examine longitudinal change in the REM behavior disorder (RBD) in the cohort of at baseline de novo Parkinson's disease (PD) subjects. Background: RBD…
  • 2016 International Congress

    Impulse control disorders after STN DBS for Parkinson’s disease

    P.G. Frederic, P. Camille, J. Nicolas, S. Abbas, F. Maria, P. Michel (Montreal, QC, Canada)

    Objective: To evaluate the prevalence and severity of impulse control disorders (ICD) and other impulsive-compulsive behaviors (ICB) in a cohort of patients with Parkinson's disease…
  • 2016 International Congress

    Analysis of the olfactory impairments in PINK1 deficient mice

    A. Hummel, A. Zimprich, L. Garret, B. Sperling, F. Giesert, J. Nagler, H. Fuchs, V. Gailus-Durner, M. Hrabé de Angelis, S.M. Koch, D. Vogt Weisenhorn, W. Wurst (Neuherberg, Germany)

    Objective: To explore the olfactory effect of PINK1 deficiency in serotonergic and dopaminergic neurons we did a behavioral analysis of young mice, deficient for PINK1…
  • 2016 International Congress

    Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetylcholinesterase and monoamine oxidase, membrane…
  • 2016 International Congress

    Validation study of Parkinson anxiety scale, Czech version

    N. Zemanová, M. Baláz (Brno, Czech Republic)

    Objective: The study aims to evaluate psychometric properties of Czech version of Parkinson Anxiety Scale (PAS), new scale developed in 2014 to measure anxiety specifically…
  • 2016 International Congress

    Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

    K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)

    Objective: The aim of this longitudinal study is to examine which variables are associated with depressive symptoms in Parkinson's disease (PD), as well as to…
  • 2016 International Congress

    Nighttime sleep problems in patients with Parkinson’s disease: Risk factors and longitudinal associations

    K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)

    Objective: The aim of this longitudinal study is to examine which factors are associated with longitudinal changes and future occurrence of nighttime sleep problems (NSP)…
  • « Previous Page
  • 1
  • …
  • 1562
  • 1563
  • 1564
  • 1565
  • 1566
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley